BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12569573)

  • 1. Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation.
    Ng A; Tang JP; Goh CH; Hui KM
    Int J Cancer; 2003 Mar; 104(2):179-87. PubMed ID: 12569573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
    Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
    Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H; Babcock K; Pitot HC
    Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors.
    Gao ZH; Suppola S; Liu J; Heikkilä P; Jänne J; Voutilainen R
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1170-6. PubMed ID: 11889182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
    Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
    Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
    Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.
    You Y; Yang W; Wang Z; Zhu H; Li H; Lin C; Ran Y
    Cell Oncol (Dordr); 2013 Jul; 36(4):323-31. PubMed ID: 23740091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
    Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
    Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas.
    Coutinho-Camillo CM; Brentani MM; Butugan O; Torloni H; Nagai MA
    Diagn Mol Pathol; 2003 Mar; 12(1):57-62. PubMed ID: 12605037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.
    Srivastava M; Hsieh S; Grinberg A; Williams-Simons L; Huang SP; Pfeifer K
    Genes Dev; 2000 May; 14(10):1186-95. PubMed ID: 10817754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
    Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
    Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma.
    Wong TS; Kwong DL; Sham JS; Tsao SW; Wei WI; Kwong YL; Yuen AP
    Clin Cancer Res; 2003 Aug; 9(8):3042-6. PubMed ID: 12912954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray.
    Zhang B; Nie X; Xiao B; Xiang J; Shen S; Gong J; Zhou M; Zhu S; Zhou J; Qian J; Lu H; He X; Li X; Hu G; Li G
    Genes Chromosomes Cancer; 2003 Sep; 38(1):80-90. PubMed ID: 12874788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.